May metallic biomaterials used for orthopaedic implants promote carcinogenesis? Preliminary transcriptomic research on human chondrocytes

• Autorzy: Walkowiak-Przybyło Magdalena

Identyfikatory

DOI

10.34821/eng.biomat.157.2020.15-19

• Języki publikacji: EN

Abstrakty

EN

The aim of this research was to assess the risk of carcinogenesis induced by the metallic materials intended for orthopaedic implants. The report is an analytical summary of changes in the expression of cancer-related genes in human chondrocytes of normal and neoplastic phenotype. Cq values (quantification cycle values) obtained from qRT-PCR reactions (quantitative real-time polymerase chain reactions) were used to count Fc values (fold change values) for each gene. Differences in Fc values obtained for primary and cancer cells grown on the surface of medical steel AISI316L and titanium-aluminum-vanadium alloy Ti6Al4V were then analyzed by t-Student test. The results indicate that for cancer cells grown on the surfaces of both examined materials the fold change greater than 2, usually considered essential, was found for LUM gene involved in sarcoma induction. For FOS gene, also involved in sarcoma induction, the Fc value was also very close to 2 in the primary cells exposed to Ti6Al4V alloy. The remaining observed changes were rather subtle, although they cannot be omitted from further studies because differences in gene expression in primary and tumor cells grown on the same biomaterial were statistically significant in several cases. The compilation of qRT-PCR experiments carried out on primary and cancer cells in parallel allowed to identify possible future contraindications for patients with a genetic predisposition to cancer or with cancer history.

Słowa kluczowe

EN

transcriptomics; qRT-PCR; gene expression; orthopaedic implants; cancer; chondrocytes

• Wydawca: Polish Society for Biomaterials in Cracow
• Czasopismo: Engineering of Biomaterials
• Rocznik: 2020
• Tom: Vol. 23, no. 157
• Strony: 15--19
• Opis fizyczny: Bibliogr. 16 poz., rys., tab.

Twórcy

autor

Walkowiak-Przybyło Magdalena

• Institute of Materials Science and Engineering, Lodz University of Technology, Stefanowskiego 1/15, 90-924 Łódź, Poland

Bibliografia

• [1] Kaur M., Singh K.: Review on titanium and titanium based alloys as biomaterials for orthopaedic applications. Mater Sci Eng C Mater Biol Appl. 102 (2019) 844-862.
• [2] Gotman I.: Characteristics of metals used in implants. J Endourol. 11(6) (1997) 383-389.
• [3] Chenchen W., Hongxing H., Zhipeng L., Yifan S., Yong X., Gangqiang Z., Xiangqiong Z., Jun D., Shichang Z., Tianhui R., Yadong Z.: Enhanced Osseointegration of Titanium Alloy Implants with Laser Microgrooved Surfaces and Graphene Oxide Coating. ACS Appl Mater Interfaces 11(43) (2019) 39470-39483.
• [4] Jeelani S., Rajkumar E. et al.: Squamous cell carcinoma and dental implants: A systematic review of case reports. J Pharm Bioallied Sci. 7(2) (2015) S378–S380.
• [5] Smith A.J., Dieppe P. et al.: Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics. BMJ (2012) 344.
• [6] Levasic V., Milosev I. et al.: Risk of cancer after primary total hip replacement: The influence of bearings, cementation and the material of the stem. Acta Orthop. 89(2) (2018) 234–239.
• [7] Mustaki L., Goetti P., Gallusser N., Morattel B., Rüdiger H., Cherix S.: Unrecognized Chondrosarcoma as a Cause of Total Hip Arthroplasty Failure. Arthroplast Today 7 (2021) 84-90.
• [8] Herget G.W., Strohm P., Rottenburger C., Kontny U., Krauß T., Bohm J., Sudkamp N., Uhl M.: Insights into Enchondroma, Enchon¬dromatosis and the risk of secondary Chondrosarcoma. Review of the literature with an emphasis on the clinical behaviour, radiology, malignant transformation and the follow up. Neoplasma 61(4) (2014) 365-378.
• [9] Komorowski P., Siatkowska M., Kamińska M., Jakubowski W., Walczyńska M., Walkowiak-Przybyło M., Szymański W., Piersa K., Wielowski P., Sokołowska P., Białkowska K., Makowski K., Elgalal M., Kierzkowska A., Ciupik L., Walkowiak B.: Comprehensive Biological Evaluation of Biomaterials Used in Spinal and Orthopedic Surgery. Materials (Basel).13(21) (2020) 4769.
• [10] Wang X., Xia Y., Liu L., Liu M., Gu N., Guang H., Zhang F.: Comparison of MTT assay, flow cytometry, and RT-PCR in the evaluation of cytotoxicity of five prosthodontic materials. J Biomed Mater Res B Appl Biomater. 95(2) (2010) 357-364.
• [11] www.genecard.org
• [12] Livak K.J., Schmittgen TD.: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25(4) (2001) 402-408.
• [13] Bustin S.A., Benes V., Garson J.A. et al: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4) (2009) 611-622.
• [14] Rueff J., Rodrigues A.S.: Cancer Drug Resistance: A Brief Over¬view from a Genetic Viewpoint. In: Rueff J., Rodrigues A. Cancer Drug Resistance. Methods in Molecular Biology. 1395 (2016) 1-18. Humana Press, New York.
• [15] Pietraszek K., Chatron-Colliet A., Brézillon S., Perreau C., Jakubiak-Augustyn A., Krotkiewski H., Maquart F.X., Wegrowski Y.: Lumican: a new inhibitor of matrix metalloproteinase-14 activity. FEBS Letters. 588 (23) (2014) 4319–4324.
• [16] Milde-Langosch K.: The Fos family of transcription factors and their role in tumourigenesis. Eur. J.Cancer. 41 (16) (2005) 2449–2461.

Uwagi

Opracowanie rekordu ze środków MNiSW, umowa Nr 461252 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2021).